Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_020376.3(PNPLA2):c.467delC (p.Pro156Leufs) | 57104 | PNPLA2 | Pathogenic | 796065307 | RCV000033095; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 822004 | 822004 | NM_020376.3:c.467delC | NP_065109.1:p.Pro156Leufs | NC_000011.9:g.822004delC | OMIM Allelic Variant:609059.0008 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.475_478dupCTCC (p.Gln160Profs) | 57104 | PNPLA2 | Pathogenic | 796065310 | RCV000055643; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 822012 | 822015 | NM_020376.3:c.475_478dupCTCC | NP_065109.1:p.Gln160Profs | NC_000011.9:g.822012_822015dupCTCC | OMIM Allelic Variant:609059.0011 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.543delC (p.Ile182Serfs) | 57104 | PNPLA2 | Pathogenic | 796065309 | RCV000055642; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 822453 | 822453 | NM_020376.3:c.543delC | NP_065109.1:p.Ile182Serfs | NC_000011.9:g.822453delC | OMIM Allelic Variant:609059.0010 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.584C>T (p.Pro195Leu) | 57104 | PNPLA2 | Pathogenic | 121918259 | RCV000001951; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 822494 | 822494 | NM_020376.3:c.584C>T | NP_065109.1:p.Pro195Leu | NC_000011.9:g.822494C>T | OMIM Allelic Variant:609059.0002 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.613dupC (p.Leu205Profs) | 57104 | PNPLA2 | Pathogenic | 796065308 | RCV000055641; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 822523 | 822523 | NM_020376.3:c.613dupC | NP_065109.1:p.Leu205Profs | NC_000011.9:g.822523dupC | OMIM Allelic Variant:609059.0009 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.749A>C (p.Gln250Pro) | 57104 | PNPLA2 | Pathogenic | 397514625 | RCV000033093; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 823579 | 823579 | NM_020376.3:c.749A>C | NP_065109.1:p.Gln250Pro | NC_000011.9:g.823579A>C | OMIM Allelic Variant:609059.0006 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NG_023394.1:g.9688G>T | 57104 | PNPLA2 | Pathogenic | 869320738 | RCV000033094; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 823588 | 823588 | NM_020376.3:c.757+1G>T | | | OMIM Allelic Variant:609059.0007 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.757+2T>C | 57104 | PNPLA2 | Pathogenic | 777539013 | RCV000033092; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 823589 | 823589 | NM_020376.3:c.757+2T>C | | NC_000011.9:g.823589T>C | OMIM Allelic Variant:609059.0005 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.808delC (p.His270Thrfs) | 57104 | PNPLA2 | Pathogenic | 796065303 | RCV000001950; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 823744 | 823744 | NM_020376.3:c.808delC | NP_065109.1:p.His270Thrfs | NC_000011.9:g.823744delC | OMIM Allelic Variant:609059.0001 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.847delC (p.Gln283Lysfs) | 57104 | PNPLA2 | Pathogenic | 796065304 | RCV000001952; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 823783 | 823783 | NM_020376.3:c.847delC | NP_065109.1:p.Gln283Lysfs | NC_000011.9:g.823783delC | OMIM Allelic Variant:609059.0003 | C1853136 610717 Neutral lipid storage disease with myopathy | | |
NM_020376.3(PNPLA2):c.865C>T (p.Gln289Ter) | 57104 | PNPLA2 | Pathogenic | 121918260 | RCV000001953; | N | MedGen:C1853136,OMIM:610717,ORPHA:98908 | 11 | 823801 | 823801 | NM_020376.3:c.865C>T | NP_065109.1:p.Gln289Ter | NC_000011.9:g.823801C>T | OMIM Allelic Variant:609059.0004 | C1853136 610717 Neutral lipid storage disease with myopathy | | |